Cannabis use during pregnancy, UTC for healthcare professionals

The maternal consumption of cannabis during pregnancy can produce restrictions on fetal growth and lower birth weight, which is more noticeable with continuous exposure. In comparison with unexposed fetuses, there are reports of reduction in fetal weight gain of -14.44 g per week and skull circumference of -0.21 mm per week in exposed individuals (CONACE, 2010). The results from a recent meta-analysis (Gunn, 2016) also report an increase in the risk of low birth weight and the probability of requiring intensive care, as well as a more significant risk of anemia for mothers.

References

CONACE. (2010). Mujeres y Tratamiento de Drogas. Santiago, Chile: Consejo Nacional para el Control de Estupefacientes.

Gunn, J. K. L., Rosales, C. B., Center, K. E., Nuñez, A., Gibson, S. J., Christ, C., & Ehiri, J. E. (2016). Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open.

Related topics

Substance use during pregnancy: https://www.issup.net/node/8722

Inhalants use during pregnancy: https://www.issup.net/node/8726

Fetal Alcohol Syndrome (FAS): https://www.issup.net/node/8723

Cerebrovascular disease due to cannabis use: https://www.issup.net/node/8743

Associations of Parental Marijuana Use With Offspring Marijuana, Tobacco, and Alcohol Use and Opioid Misuse: https://www.issup.net/node/6511